SI-BONE, Inc. (SIBN): Price and Financial Metrics


SI-BONE, Inc. (SIBN): $14.24

0.32 (+2.30%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SIBN POWR Grades


  • SIBN scores best on the Stability dimension, with a Stability rank ahead of 39.37% of US stocks.
  • SIBN's strongest trending metric is Stability; it's been moving up over the last 179 days.
  • SIBN ranks lowest in Sentiment; there it ranks in the 12th percentile.

SIBN Stock Summary

  • SIBN's went public 3.45 years ago, making it older than merely 11.1% of listed US stocks we're tracking.
  • With a price/sales ratio of 8.15, SI-BONE Inc has a higher such ratio than 82.15% of stocks in our set.
  • SIBN's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 19.82% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to SI-BONE Inc are XXII, ECOR, ACRX, ATEC, and KRMD.
  • Visit SIBN's SEC page to see the company's official filings. To visit the company's web site, go to si-bone.com.

SIBN Valuation Summary

  • In comparison to the median Healthcare stock, SIBN's EV/EBIT ratio is 167.92% lower, now standing at -19.9.
  • Over the past 35 months, SIBN's price/earnings ratio has gone up 6.2.
  • Over the past 35 months, SIBN's price/earnings ratio has gone up 6.2.

Below are key valuation metrics over time for SIBN.

Stock Date P/S P/B P/E EV/EBIT
SIBN 2021-08-31 9.5 5.3 -18.2 -19.9
SIBN 2021-08-30 9.3 5.1 -17.7 -19.3
SIBN 2021-08-27 9.3 5.1 -17.8 -19.5
SIBN 2021-08-26 9.0 5.0 -17.2 -18.8
SIBN 2021-08-25 8.8 4.9 -16.9 -18.4
SIBN 2021-08-24 8.6 4.8 -16.4 -18.0

SIBN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SIBN has a Quality Grade of C, ranking ahead of 32.78% of graded US stocks.
  • SIBN's asset turnover comes in at 0.425 -- ranking 111th of 186 Medical Equipment stocks.
  • 500 - Internal server error

The table below shows SIBN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.425 0.889 -0.227
2021-03-31 0.409 0.881 -0.230
2020-12-31 0.417 0.879 -0.268
2020-09-30 0.475 0.878 -0.305
2020-06-30 0.473 0.884 -0.313
2020-03-31 0.519 0.896 -0.281

SIBN Price Target

For more insight on analysts targets of SIBN, see our SIBN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $40.86 Average Broker Recommendation 1.36 (Strong Buy)

SIBN Stock Price Chart Interactive Chart >

Price chart for SIBN

SIBN Price/Volume Stats

Current price $14.24 52-week high $34.38
Prev. close $13.92 52-week low $11.89
Day low $13.99 Volume 14,660
Day high $14.34 Avg. volume 290,048
50-day MA $18.68 Dividend yield N/A
200-day MA $20.84 Market Cap 482.51M

SI-BONE, Inc. (SIBN) Company Bio


SI-BONE, Inc. engages in the development of invasive surgical implant system. Its product, iFuse, seeks to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded on April 2008 by Mark A. Reiley and Jeffrey W. Dunn in and is headquartered in San Jose, CA.


SIBN Latest News Stream


Event/Time News Detail
Loading, please wait...

SIBN Latest Social Stream


Loading social stream, please wait...

View Full SIBN Social Stream

Latest SIBN News From Around the Web

Below are the latest news stories about SI-BONE Inc that investors may wish to consider to help them evaluate SIBN as an investment opportunity.

SI-Bone (SIBN) Gets a Buy Rating from Needham

In a report released today, David Saxon from Needham reiterated a Buy rating on SI-Bone (SIBN – Research Report), with a price target of $30.00. The company's shares closed last Monday at $22.06. According to TipRanks.com, Saxon is a 1-star analyst with an average return of -3.8% and a 28.3% success rate. Saxon covers the Healthcare sector, focusing on stocks such as Irhythm Technologies, Alphatec Holdings, and Globus Medical. SI-Bone has an analyst consensus of Strong Buy, with a price target consensus of $33.00, representing a 56.0% upside. In a report released today, JMP Securities also reiterated a Buy rating on the stock with a $36.00 price target.

Howard Kim on TipRanks | March 1, 2022

Morgan Stanley Reaffirms Their Buy Rating on SI-Bone (SIBN)

In a report released today, Drew Ranieri from Morgan Stanley maintained a Buy rating on SI-Bone (SIBN – Research Report), with a price target of $28.00. The company's shares closed last Tuesday at $23.01. According to TipRanks.com, Ranieri is a 1-star analyst with an average return of -4.7% and a 40.0% success rate. Ranieri covers the Healthcare sector, focusing on stocks such as Treace Medical Concepts, Zimmer Biomet Holdings, and Baxter International. SI-Bone has an analyst consensus of Strong Buy, with a price target consensus of $32.00, which is a 44.5% upside from current levels.

Catie Powers on TipRanks | March 1, 2022

SI-BONE, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Issues 2022 Revenue Guidance

SANTA CLARA, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter and full year ended December 31, 2021.

GlobeNewswire | February 28, 2022

SI-BONE, Inc. (SIBN) CEO Laura Francis on Q4 2021 Results - Earnings Call Transcript

No summary available.

Seeking Alpha | February 28, 2022

SI-BONE GAAP EPS of -$0.43 misses by $0.05, revenue of $25.2M beats by $0.39M

SI-BONE press release (SIBN): Q4 GAAP EPS of -$0.43 misses by $0.05.Revenue of $25.2M (+13.8% Y/Y) beats by $0.39M.

Seeking Alpha | February 28, 2022

Read More 'SIBN' Stories Here

SIBN Price Returns

1-mo -30.67%
3-mo -33.21%
6-mo -28.87%
1-year -55.22%
3-year -10.61%
5-year N/A
YTD -35.88%
2021 -25.72%
2020 39.07%
2019 2.92%
2018 N/A
2017 N/A

Continue Researching SIBN

Here are a few links from around the web to help you further your research on SI-BONE Inc's stock as an investment opportunity:

SI-BONE Inc (SIBN) Stock Price | Nasdaq
SI-BONE Inc (SIBN) Stock Quote, History and News - Yahoo Finance
SI-BONE Inc (SIBN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5473 seconds.